1361952-84-2

Basic information

• Product Name: 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide
• Synonyms: 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide
• CAS NO: 1361952-84-2
• Molecular Weight: 486.614
• Mol File: 1361952-84-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide(1361952-84-2)
• EPA Substance Registry System: 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide(1361952-84-2)

Safety Data

• Hazardous Substances Data: 1361952-84-2(Hazardous Substances Data)

Upstream product

• 40896-62-6 (3-Aminomethylphenyl)methanol Hydrochloride 
• 530-62-1 1,1'-carbonyldiimidazole 

Relevant articles and documents

DIARYLMETHYL AND RELATED COMPOUNDS

This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7, Ar1, Ar2, E, a, b, c, and z are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.